Natriuretic Peptide Screening for the Identification, Assessment, and Treatment of Heart Failure
Tuesday, June 11, 2019
2 - 3 PM ET

The management of heart failure is constantly evolving and advancing. Heart failure guidelines recommend prevention through optimal management of risk factors and comorbidities. Substantial evidence now exists which support the use of natriuretic peptide biomarkers to assist with the diagnosis or exclusion of heart failure in both chronic and acute care settings. This educational program will address these findings.

This activity is accredited for physicians and nurses (see CME Assessment for post-test). The webinar will be available on-demand after the live portion with downloads of the transcript and educational slides posted (see Downloads). There is no charge for this activity.

Medavera, Inc. has partnered with Community Health Ventures, Inc., the National Association of Community Health Centers' (NACHC) business affiliate to provide this educational program to healthcare professionals.

National Association of Community Health Centers Community Health Ventures

Planned and developed by Medavera, Inc. with educational support provided by Quidel.

Medavera is a leader in medical education. Our team of experienced medical and scientific professionals identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content and utilize formats that will provide the best learning opportunity. Great content, respected leaders, and user-friendly platforms create successful interactions and learning.
© Medavera, Inc. 2021. All rights reserved.